Resistance to Immunotoxins in Cancer Therapy / edited by Rama Shanker Verma, Benjamin Bonavida.
Contributor(s): SpringerLink (Online service)
| Verma, Rama Shanker, editor literario
| Bonavida, Benjamin, editor literario
Material type:
E-bookSeries: (Resistance to Targeted Anti-Cancer Therapeutics, 2196-5501; 6).Publisher: Cham, Switzerland : Springer, 2015Description: 1 recurso en línea (XVI, 249 páginas) : 22 ilustraciones, 19 ilustraciones en color.ISBN: 9783319172750.Subject: Resistencia a los medicamentos
Abstract: This volume is a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. It contains a detailed review of the history and development of targeted therapy. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance. Each chapter discusses different aspects of resistance and covers all the factors that may contribute to resistance in cancer cells. Finally, this volume highlights the recent findings and advances associated with tackling cancer resistance.
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | QR185.8.A58 R475 2015 EB (Browse shelf(Opens below)) | .i11569554 | Acceso electrónico | eBOOK .i11569554 |
This volume is a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. It contains a detailed review of the history and development of targeted therapy. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance. Each chapter discusses different aspects of resistance and covers all the factors that may contribute to resistance in cancer cells. Finally, this volume highlights the recent findings and advances associated with tackling cancer resistance.
There are no comments on this title.